Initiative For Medicines, Access & Knowledge (I Mak) Opposition, Sofosbuvir, (Us 7,429,572)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,964,580)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,735,372)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,633,309)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,284,342)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,393,256)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access and Knowledge (I-MAK) opposition, Sofosbuvir, (CN 200480019148.4)
Countries: China Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))
Countries: India Date: 2017